1-7 of 7
Susan K Parsons, MDMRP
Close
Sort by
Journal Articles

Health-Related Quality of Life (HRQL) Among Hospitalized Adults with Sickle Cell Disease (SCD): Incorporating Patient-Reported Outcome (PRO) Measures in Clinical Care

Kimberly S Esham, MD, Angie Mae Rodday, PhD MS, Ruth Ann Weidner, MBA, MRP, Rachel J. Buchsbaum, MD, Hedy P Smith, MD PhD, Susan K Parsons, MDMRP
Journal: Blood
Blood (2016) 128 (22): 5962.
https://doi.org/10.1182/blood.V128.22.5962.5962
Published: 2016
Journal Articles

Assessing the Risk of Cardiac Toxicity after Contemporary Treatment for Hodgkin Lymphoma (HL): A Multidisciplinary Systematic Review

Julie Fu, MD MA, Jenica Upshaw, MDMS, Michael J. Kelly, MD MPH, MS, Joshua T Cohen, PhD, Tully Saunders, MBA, Andrew M Evens, DO, MSc, FACP, Susan K Parsons, MDMRP
Journal: Blood
Blood (2016) 128 (22): 3564.
https://doi.org/10.1182/blood.V128.22.3564.3564
Published: 2016
Journal Articles

Comparison of Survival and Costs of Rituximab-Based Chemotherapy for Initial Therapy of Follicular Lymphoma in Elderly Patients

Gunjan L. Shah, MDMS, Aaron Winn, MPP, Pei-Jung Lin, PhDMS, Anita J Kumar, MDMS, Susan K Parsons, MDMRP
Journal: Blood
Blood (2016) 128 (22): 2354.
https://doi.org/10.1182/blood.V128.22.2354.2354
Published: 2016
Journal Articles

Patient and Hospital Characteristics Associated with Increased Length of Stay for Patients with Acute Myeloid Leukemia (AML): An Analysis from the 2012 National Inpatient Sample (NIS)

Anita J Kumar, MDMS, Toby Henzer, Angie Mae Rodday, PhDMS, Susan K Parsons, MDMRP
Journal: Blood
Blood (2016) 128 (22): 3572.
https://doi.org/10.1182/blood.V128.22.3572.3572
Published: 2016
Journal Articles

Approach and Feasibility of Patient-Reported Outcomes (PROs) in a Phase III Clinical Trial for Advanced Stage Classical Hodgkin Lymphoma (cHL) in Children and Adolescents

Tara O Henderson, MDMPH, Sharon M Castellino, MD, Frank G Keller, MD, Kara M. Kelly, MD, Rachael Curtis, Rena M Conti, PhD, Susan K Parsons, MDMRP
Journal: Blood
Blood (2016) 128 (22): 3583.
https://doi.org/10.1182/blood.V128.22.3583.3583
Published: 2016
Journal Articles

An Adjustable Markov Model to Project Life Expectancy (LE) for Early Stage Favorable Risk Hodgkin Lymphoma Patients Treated with Contemporary Therapy

Michael J. Kelly, MD MPH, MS, Susan K Parsons, MDMRP, David C. Hodgson, MD, Joshua T Cohen, PhD, Jennifer M Yeh, MD PhD, Jeremy S. Abramson, MD, Debra L. Friedman, MD MS, Tara O Henderson, MDMPH, Peter W Johnson, MD, Stephen G Pauker, MD, John M. Raemaekers, MD PhD, Jane N. Winter, MD, Kara M. Kelly, MD, Ralph M. Meyer, MD, Sharon M Castellino, MD, Andrew M. Evens, DO, MSc
Journal: Blood
Blood (2015) 126 (23): 2635.
https://doi.org/10.1182/blood.V126.23.2635.2635
Published: 2015
Journal Articles

Outcomes in Adolescents and Young Adults (AYA) with Hodgkin Lymphoma (HL) Treated on US Cooperative Group Protocols: An Adult Intergroup (E2496) and Children's Oncology Group (COG AHOD0031) Comparative Analysis

Tara O Henderson, MDMPH, Susan K Parsons, MDMRP, Kristen Wroblewski, MS, Lu Chen, PhD, Fangxin Hong, PhD, Sonali M. Smith, MD, Jennifer McNeer, MD MS, Ranjana Advani, Randy D. Gascoyne, Louis Constine, MD, Sandra J Horning, MD, Nancy L Bartlett, MD, Bijal D. Shah, MD, Joseph M. Connors, MD, John P. Leonard, MD, Brad S. Kahl, MD, Kara M. Kelly, MD, Cindy Schwartz, MD, Debra L. Friedman, MD MS, Leo I. Gordon, MD, Andrew M. Evens, DO, MSc
Journal: Blood
Blood (2015) 126 (23): 2636.
https://doi.org/10.1182/blood.V126.23.2636.2636
Published: 2015